Welcome to our dedicated page for Cardiff Lexingto news (Ticker: CDIX), a resource for investors and traders seeking the latest updates and insights on Cardiff Lexingto stock.
Cardiff Lexington Corporation reports operating and capital-market developments for a healthcare services holding company focused on orthopedic, spine and pain-management platforms. Its current revenue is derived from Nova Ortho and Spine, which operates regional specialty and ancillary orthopedic care centers in Florida and Georgia that provide diagnostic services, surgical services, primary care evaluations, interventional pain management and specialty consultations for traumatic injury patients.
Recurring updates include financial results, patient-volume and procedure mix, facility and clinician additions, activity at Nova Ortho and Spine locations, acquisition strategy for orthopedic practices and related healthcare assets, OTC market status, reverse stock split actions, registration-statement activity and board governance changes.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Cardiff Lexington Corporation (OTC PINK:CDIX) reported its 3rd quarter financial results for the period ending September 30, 2022. Key highlights include:
- Stockholders' Equity: Increased by 131%, totaling $6.4 million.
- Total Assets: Rose by 43%, reaching $15.9 million.
- Revenue: Grew by 47%, amounting to $9.4 million.
- Gross Margin: Up by 43%, totaling $6 million.
- Net Loss: Decreased by $1.9 million to ($813,054).
Management expressed optimism about moving beyond cash flow survival.
Cardiff Lexington Corporation (OTC PINK:CDIX) reported remarkable financial results for the 2nd quarter ended June 30, 2022. The company achieved a 95% increase in revenue to $6.07 million, compared to $3.11 million for the same period in 2021. Their gross margin also rose by 92% to $3.82 million. Notably, net income reached $61,826, a $3.1 million improvement from last year, while net loss decreased by $4.33 million. CEO Alex Cunningham expressed optimism for continued growth, anticipating strong results for the impending third quarter.
Cardiff Lexington Corporation (OTC PINK:CDIX) reported a significant turnaround in its financial results for the year ended December 31, 2021. Total stockholders' equity soared to $2.78 million from ($8.87 million) in 2020, marking an increase of $11.65 million. Total assets rose by 126% to $11.16 million, while total liabilities dropped by 40% to $8.38 million. Revenue surged 190% to $10.01 million, and gross margin improved 245% to $6.16 million. Although there was a net loss of ($409,707), this represented an 85% decrease in losses compared to the previous year.